WTX-607, an oral small molecule being developed by Wavebreak, binds to and blocks the formation of small alpha-synuclein protein clumps — toxic aggregates linked to nerve damage in Parkinson’s disease […] The post Drug blocks toxic alpha-synuclein clumps in human brain tissue in lab appeared first on Parkinson's News Today.
